Welcome to LookChem.com Sign In|Join Free

CAS

  • or

174603-55-5

3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID is a chemical compound with the molecular formula C9H8BrFO2, characterized by its bromo and fluoro substituents on the phenyl ring. It is a derivative of propionic acid and has potential applications in both the pharmaceutical and chemical industries due to its anti-inflammatory and analgesic properties.

174603-55-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 174603-55-5 Structure

  • Basic information

    1. Product Name: 3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID
    2. Synonyms: 3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID;3-(2-broMo-4-fluorophenyl)propanoic acid;Benzenepropanoic acid, 2-broMo-4-fluoro-
    3. CAS NO:174603-55-5
    4. Molecular Formula: C9H8BrFO2
    5. Molecular Weight: 247.06
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 174603-55-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID(174603-55-5)
    11. EPA Substance Registry System: 3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID(174603-55-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 174603-55-5(Hazardous Substances Data)

174603-55-5 Usage

Uses

Used in Pharmaceutical Research:
3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID is used as a pharmaceutical candidate for its potential anti-inflammatory and analgesic properties. It is being studied for its potential use in the development of new drugs for the treatment of pain and inflammation-related conditions.
Used in Organic Synthesis:
3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID is used as a building block in organic synthesis for the preparation of various functionalized compounds. Its unique structure with bromo and fluoro substituents makes it a valuable intermediate in the synthesis of pharmaceuticals and other specialty chemicals.
Used in Chemical Industry:
3-(2-BROMO-4-FLUORO-PHENYL)-PROPIONIC ACID is used in the chemical industry for the synthesis of various functionalized compounds, contributing to the development of new materials and products with specific properties and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 174603-55-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,6,0 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 174603-55:
(8*1)+(7*7)+(6*4)+(5*6)+(4*0)+(3*3)+(2*5)+(1*5)=135
135 % 10 = 5
So 174603-55-5 is a valid CAS Registry Number.

174603-55-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2-Bromo-4-fluorophenyl)propionic acid

1.2 Other means of identification

Product number -
Other names 3-(2-bromo-4-fluorophenyl)propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174603-55-5 SDS

174603-55-5Relevant articles and documents

QUINOXALINE DERIVATIVES

-

, (2021/07/24)

The present invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

Highly Diastereoselective Synthesis of Medium-Sized Carbocycle-Fused Piperidines via Sequential Hydride Shift Triggered Double C(sp3)-H Bond Functionalization

Kataoka, Miyabi,Otawa, Yuna,Ido, Natsuki,Mori, Keiji

supporting information, p. 9334 - 9338 (2019/11/19)

Herein we report a diastereoselective synthesis of medium-sized carbocycle-fused piperidines via [1,n (n = 6, 7)]-[1,5]-sequential hydride shift triggered double C(sp3)-H bond functionalization. When cinnamylidene malonates having N,N-dibenzyl propylamine moiety were treated with 5 mol % of Yb(OTf)3, a [1,6]-[1,5]-sequential hydride shift/cyclization process proceeded to afford seven-membered carbocycle-fused piperidines with excellent diastereoselectivities. This sequential system was applicable to the synthesis of eight-membered carbocycle-fused piperidines by an unprecedented [1,7]-[1,5]-sequential hydride shift/cyclization process.

Construction of seven-and eight-membered carbocycles by Lewis acid catalyzed C(sp3)-H bond functionalization

Otawa, Yuna,Mori, Keiji

supporting information, p. 13856 - 13859 (2019/11/21)

We achieved a concise construction of seven-and eight-membered carbocycles via Lewis acid catalyzed C(sp3)-H bond functionalization. In these reactions, a quite rare [1,6 (or 7)]-hydride shift/cyclization process proceeded smoothly to afford seven-and eight-membered carbocycles with good chemical yields starting from substrates with high conformational freedom.

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

-

, (2015/03/28)

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 3-aryl-5-substituted- 2/-/-isoquinolin-1-one compounds that, inter alia, inhibit PARP (e.g., PARP1, TNKS1, TNKS2, e

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS

-

Page/Page column 114, (2013/10/21)

The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activity

Musso, David L.,Orr, G. Faye,Cochran, Felicia R.,Kelley, James L.,Selph, Jeffrey L.,Rigdon, Greg C.,Cooper, Barrett R.,Jones, Michael L.

, p. 409 - 416 (2007/10/03)

Extension of the structure-activity relationship studies that led to the discovery of the nonsedating potent muscle relaxant, antiinflammatory, and analgesic agent (E)-2-(4,6-difluoro-1-indanylidene)acetamide, 1, has given rise to (E)-2-(4-chloro-6-fluoro

Amide derivatives and their therapeutic use

-

, (2008/06/13)

A compound of formula (I), wherein R1 and R2 are independently selected from chloro, fluoro, bromo, C1-6 alkyl, C1-6 alkoxy or C1-6 haloalkyl provided that both R1 and R2 are not

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 174603-55-5